IL10 and myeloid sarcoma: The gut microbial dysbiosis in MS leads to the reduction of microbes which can elicit an anti-inflammatory response through immune cells like T regulatory cells, regulatory B cells and Interleukin 10 (IL-10) in host (Shahi et al., 2017).